Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Decision Support Systems, Clinical | 7 | 2024 | 1161 | 1.330 |
Why?
|
Emergency Service, Hospital | 20 | 2024 | 7788 | 0.900 |
Why?
|
Sepsis | 7 | 2024 | 2593 | 0.790 |
Why?
|
Tetanus Toxoid | 1 | 2021 | 193 | 0.730 |
Why?
|
Immunization Schedule | 1 | 2021 | 224 | 0.690 |
Why?
|
Patient Admission | 1 | 2023 | 1383 | 0.500 |
Why?
|
Shock, Septic | 3 | 2023 | 761 | 0.420 |
Why?
|
Inpatients | 1 | 2023 | 2580 | 0.370 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1849 | 0.360 |
Why?
|
Patient Discharge | 3 | 2023 | 3460 | 0.340 |
Why?
|
Disease Management | 1 | 2020 | 2495 | 0.340 |
Why?
|
Radiology Department, Hospital | 1 | 2013 | 405 | 0.330 |
Why?
|
Anti-Bacterial Agents | 4 | 2023 | 7379 | 0.320 |
Why?
|
Vaccination | 1 | 2021 | 3354 | 0.320 |
Why?
|
Hospitalization | 3 | 2023 | 10732 | 0.310 |
Why?
|
Incidental Findings | 1 | 2013 | 699 | 0.300 |
Why?
|
Bayes Theorem | 2 | 2023 | 2322 | 0.240 |
Why?
|
Electronic Health Records | 5 | 2023 | 4737 | 0.240 |
Why?
|
Natural Language Processing | 1 | 2013 | 1128 | 0.230 |
Why?
|
Buprenorphine | 2 | 2022 | 646 | 0.230 |
Why?
|
Retrospective Studies | 17 | 2024 | 80125 | 0.220 |
Why?
|
Opioid-Related Disorders | 3 | 2022 | 2122 | 0.200 |
Why?
|
Anthozoa | 1 | 2021 | 65 | 0.190 |
Why?
|
Soft Tissue Infections | 1 | 2022 | 168 | 0.180 |
Why?
|
Cardiac Tamponade | 1 | 2022 | 174 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8604 | 0.180 |
Why?
|
Travel Medicine | 1 | 2020 | 83 | 0.170 |
Why?
|
Pericardial Effusion | 1 | 2022 | 247 | 0.170 |
Why?
|
Models, Immunological | 1 | 2022 | 505 | 0.170 |
Why?
|
Communicable Diseases, Emerging | 1 | 2020 | 150 | 0.160 |
Why?
|
Catheter-Related Infections | 1 | 2021 | 272 | 0.150 |
Why?
|
Substance Abuse, Intravenous | 1 | 2022 | 529 | 0.150 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2021 | 278 | 0.150 |
Why?
|
Unnecessary Procedures | 1 | 2021 | 413 | 0.150 |
Why?
|
Paraproteinemias | 1 | 2020 | 246 | 0.140 |
Why?
|
Emergency Medicine | 2 | 2023 | 1195 | 0.130 |
Why?
|
Vulnerable Populations | 1 | 2021 | 696 | 0.130 |
Why?
|
Medically Uninsured | 1 | 2021 | 843 | 0.130 |
Why?
|
Telemedicine | 2 | 2023 | 2997 | 0.120 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 694 | 0.120 |
Why?
|
Adult | 14 | 2024 | 219353 | 0.120 |
Why?
|
Humans | 33 | 2024 | 759098 | 0.120 |
Why?
|
Medical Order Entry Systems | 1 | 2020 | 522 | 0.120 |
Why?
|
Length of Stay | 3 | 2023 | 6452 | 0.120 |
Why?
|
Cost Savings | 1 | 2020 | 921 | 0.120 |
Why?
|
Communicable Disease Control | 1 | 2020 | 844 | 0.110 |
Why?
|
Massachusetts | 3 | 2021 | 8788 | 0.110 |
Why?
|
Hypnotics and Sedatives | 1 | 2021 | 1177 | 0.110 |
Why?
|
Algorithms | 1 | 2013 | 13951 | 0.100 |
Why?
|
Cross Infection | 1 | 2021 | 1434 | 0.100 |
Why?
|
Residence Characteristics | 1 | 2021 | 2035 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2610 | 0.090 |
Why?
|
Crowding | 2 | 2022 | 142 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2530 | 0.090 |
Why?
|
Feedback | 2 | 2023 | 791 | 0.080 |
Why?
|
Single-Blind Method | 1 | 2013 | 1574 | 0.080 |
Why?
|
Radiology Information Systems | 1 | 2013 | 528 | 0.080 |
Why?
|
Poverty | 1 | 2021 | 2679 | 0.080 |
Why?
|
Efficiency, Organizational | 1 | 2013 | 694 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10825 | 0.080 |
Why?
|
Hypertension, Pulmonary | 1 | 2019 | 1567 | 0.080 |
Why?
|
Hospital Mortality | 4 | 2023 | 5414 | 0.080 |
Why?
|
Information Storage and Retrieval | 1 | 2013 | 821 | 0.080 |
Why?
|
Anticoagulants | 1 | 2023 | 4896 | 0.070 |
Why?
|
Medical Records Systems, Computerized | 1 | 2013 | 1192 | 0.070 |
Why?
|
Medical Informatics | 1 | 2013 | 732 | 0.070 |
Why?
|
Workflow | 2 | 2022 | 850 | 0.070 |
Why?
|
Quality Improvement | 1 | 2021 | 3835 | 0.060 |
Why?
|
Male | 12 | 2024 | 358602 | 0.060 |
Why?
|
Middle Aged | 8 | 2024 | 219628 | 0.060 |
Why?
|
Aged | 9 | 2024 | 168615 | 0.060 |
Why?
|
Substance-Related Disorders | 1 | 2021 | 4358 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5419 | 0.060 |
Why?
|
Prospective Studies | 3 | 2023 | 54190 | 0.060 |
Why?
|
Hospitals | 3 | 2022 | 3929 | 0.060 |
Why?
|
Risk Assessment | 2 | 2022 | 24049 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2022 | 39213 | 0.050 |
Why?
|
Female | 10 | 2024 | 390174 | 0.050 |
Why?
|
Pericardiocentesis | 1 | 2022 | 79 | 0.050 |
Why?
|
Guideline Adherence | 2 | 2023 | 2283 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2022 | 58864 | 0.050 |
Why?
|
Vital Signs | 1 | 2022 | 142 | 0.050 |
Why?
|
Young Adult | 3 | 2024 | 58477 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2022 | 393 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20027 | 0.040 |
Why?
|
Likelihood Functions | 1 | 2022 | 988 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3526 | 0.040 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2021 | 330 | 0.040 |
Why?
|
Area Under Curve | 1 | 2022 | 1634 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 25853 | 0.040 |
Why?
|
Opiate Substitution Treatment | 1 | 2021 | 426 | 0.040 |
Why?
|
Narcotic Antagonists | 1 | 2021 | 580 | 0.030 |
Why?
|
Efficiency | 1 | 2020 | 477 | 0.030 |
Why?
|
Patient Transfer | 1 | 2023 | 775 | 0.030 |
Why?
|
Minority Groups | 1 | 2024 | 1198 | 0.030 |
Why?
|
Risk Factors | 1 | 2023 | 74167 | 0.030 |
Why?
|
Reimbursement, Incentive | 1 | 2021 | 543 | 0.030 |
Why?
|
Data Mining | 1 | 2021 | 550 | 0.030 |
Why?
|
Adolescent | 2 | 2022 | 87551 | 0.030 |
Why?
|
Program Development | 1 | 2022 | 1295 | 0.030 |
Why?
|
Abdomen | 1 | 2021 | 1120 | 0.030 |
Why?
|
Physical Examination | 1 | 2021 | 1243 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2021 | 1064 | 0.030 |
Why?
|
United States | 4 | 2024 | 72238 | 0.030 |
Why?
|
Travel | 1 | 2020 | 787 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5310 | 0.030 |
Why?
|
ROC Curve | 1 | 2022 | 3569 | 0.030 |
Why?
|
Health Records, Personal | 1 | 2013 | 126 | 0.030 |
Why?
|
Linear Models | 1 | 2022 | 5876 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3143 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2020 | 1999 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9712 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 41266 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2022 | 3598 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3308 | 0.020 |
Why?
|
Clinical Competence | 1 | 2023 | 4775 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7790 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2019 | 3730 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8050 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2022 | 15262 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3323 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10550 | 0.020 |
Why?
|
Child | 2 | 2023 | 79604 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2022 | 64867 | 0.020 |
Why?
|
Medicare | 1 | 2021 | 6763 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21344 | 0.010 |
Why?
|
Time Factors | 1 | 2023 | 40083 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 29559 | 0.010 |
Why?
|
Boston | 1 | 2013 | 9274 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20461 | 0.010 |
Why?
|
Animals | 1 | 2021 | 167531 | 0.010 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(86)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_